Date updated:03-13-2009
Each week I like to find beaten-up stocks that I believe have the potential to snap back in coming days due to a specific event driven catalyst that could either move the price higher or lower. I especially like when these stocks with near-term growth potential also qualify as solid long-term plays. And with the market down huge, there are penalty of short-term opportunities out there

-
STEC
Stec - $11.96
- -3.00%
- $12.39
STEC Inc. (STEC): Long ahead of earnings. STEC will likely gap higher this week due to an earnings catalyst. Last quarter came ahead of estimates with Non-GAAP gross profit margin was 34.1% for the third quarter of 2008, compared to 31.1% for the third quarter of 2007, and 35.3% for the second quarter of 2008. Non-GAAP diluted earnings per share was $0.10 for the third quarter of 2008, compared to $0.06 for the third quarter of 2007, and $0.09 for the second quarter of 2008. GAAP gross profit margin was 32.1% for the third quarter of 2008, compared to 29.0% for the third quarter of 2007, and 32.3% for the second quarter of 2008. In Novomber, the board approved a $10 million dollar buyback. Needham has a "strong buy" on STEC with a $15 price target (3x current price)

-
NPSP
Nps Pharmaceutica - $4.03
- -3.36%
- $4.11
NPS Pharmaceuticals (NPSP): Long ahead of earnings. Shares of NPS Pharmaceutical have been relative depressed as of late, despite a broader biotech rally the last several months. Last quarter, NPS Pharma earned $1.2 million, or 3 cents per share, compared with a loss of $14.8 million, or 32 cents per share, during the same period a year earlier. Revenue rose to $27 million from $13.1 million on increased license and royalty fees. Analysts were expecting a loss of 17 cents per share on revenue of $27 million. NPS said revenue gains resulted from licensing fees from Nycomed for Gattex, which is designed to treat short-bowel syndrome. It also received royalty revenue on sales of Amgen's (AMGN) Sensipar. Some of the top biotech investors are in NPS, such has the $7 billion New York City-based biotech hedge fund OrbiMed Advisors, which is the second-largest investor with an 8.39% stake. In addition, Merlin BioMed Group has a 2.59% stake, and Renaissance Technologies has a 7.81% stake. Once investors see NPS’s earnings with an update on their pipeline, they will likely bid the stock substantially higher.

-
AVAV
Aerovironment - $24.24
- -2.06%
- $24.86
AeroVironment (AVAV): Recently Jim Cramer said “I'm afraid that people are clustered in thinking that this is the Obama defense stock”, adding “We've got to get over the idea that we can make money on the long side with Obama”. Shares of AeroVironment are up 60% for the year which compares to a decline in the Standard & Poor’s 500 index of 56%.

-
POT
Potash Corporatio - $121.16
- -1.40%
- $123.85
Potash Corp. of Saskatchewan (POT): Potash Corp. of Saskatchewan is the world’s lowest-cost producer and supplier of Potash in the world. The Potash fertilizer is the highest yielding, naturally produced fertilizer known to man. In 2008, PotashCorp produced north of 15 million tons, which represents almost 25% of the total amount of Potash consumed in the world. Gross margins went from just $300 million dollars in 2003 to $3.5 billion in 2008 with an estimated figure of $5.5 billion in 2009.

-
CASY
Caseys General St - $30.63
- +1.66%
- $30.325
No Analysis added

-
KR
Kroger Company (t - $21.64
- -2.70%
- $22.20
No Analysis added

-
OPTR
Optimer Pharmaceu - $13.19
- -1.71%
- $13.49
No Analysis added

-
MOS
Mosaic Company (t - $58.42
- -1.91%
- $59.74
No Analysis added
- Rocket Stocks for the week of March 9th – March 13th's Blog
- No Blogs Found
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Fidelity Select Pharma...
- 3. Calamos Advisors
- 4. BlackRock Health Scien...
- 5. Schwab Health Care SWHFX
- show all
- Top Do-It-Yourself Portfolios
- » jgroov Portfolio 1
- » ben johnson
- » my holdings
- » SC TRADE OF THE DAY
- » kudos
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Jonas Elmerraji Posted on March 19, 2010 Last week was a comparatively quiet one for dividend stocks, particularly given the slew of investor payouts that capped off...
By Roberto Pedone Posted on March 19, 2010 According to Jim Cramer, the stock market could catch a cold from health care reform. In a March 18 RealMoney blog post, he s...
By Jonas Elmerraji Posted on March 18, 2010 Short sellers beware; stocks are seeing a buyer’s market this week. Now that the S&P 500 and the Dow Jones Industrial Aver...
By Roberto Pedone Posted on March 18, 2010 According to CNBC’s “Fast Money” traders, the easy money trades are still the way to play this market after the Federal...
A. The only one I own : SLX,
too hard pick a winner out all of them
Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more
Below is the list of the top open-market insider buys filed at the SEC on Mar. 18, 2010. more
Here is the stock list of some of the largest % losers from Mar. 19, 2010. more













Comments not available